BETAPharmaceuticals
BETA Technologies, Inc Class A Common Stock — PE Ratio & Valuation Analysis
₹1661.10
+0.00%
Current P/E38.38xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E47.0x18.3% below avg
⚠️
20.8% Premium to Industry
BETA P/E 38.38x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹36.10 | ₹2009 | 55.7x |
| 2023 | ₹30.43 | ₹1470 | 48.3x |
| 2022 | ₹24.59 | ₹710 | 28.9x |
| 2021 | ₹11.62 | ₹640 | 55.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding BETA Technologies, Inc Class A Common Stock Valuation
BETA Technologies, Inc Class A Common Stock (BETA) currently trades at 38.38x earnings. The Pharmaceuticals sector average PE is 31.77x. BETA commands a premium, reflecting high growth expectations. Historically, BETA has traded at an average PE of 47.0x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
25.86%
Dividend Yield
0.00%
More on BETA Technologies, Inc Class A Common Stock
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.